Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Tango Therapeutics (NASDAQ: TNGX) announced that Malte Peters, M.D., President and CEO, will appear in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026 at 2:00 PM EST.

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX) announced that Malte Peters, M.D., President and CEO, will appear in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026 at 2:00 PM EST. The event will be webcast live and a replay will be archived on the company website for 90 days.

Argus Feb 3 session

+5.11% close to close Open Argus

Details

News Market Reaction – TNGX

In the Feb 3 session, TNGX gained 5.11%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.1% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +5.1% in the session following this news. A strong positive reaction aligns with the pattern of investor interest around Tango’s conference and visibility events, even when they are informational rather than clinical. Prior updates, including major conferences and leadership changes, produced single-day moves between about -8% and +2%. If gains extended beyond that range, investors would need to weigh the non-fundamental nature of this summit appearance against existing resale and ATM capacities disclosed in recent filings.

Key Figures

Summit date: February 12, 2026 Event time: 2:00 PM EST Webcast archive period: 90 days

Summit date

February 12, 2026

Date of Guggenheim Emerging Outlook: Biotech fireside chat

Event time

2:00 PM EST

Scheduled time for the fireside chat

Webcast archive period

90 days

Replay available on company website after presentation

Historical Context

5 past events · Latest: Jan 08

5 events

1. Jan 08

   CEO transition

   24h Move

   -6.2%

   Founding CEO retires; Malte Peters becomes President and CEO.

2. Jan 05

   Board appointment

   24h Move

   -0.2%

   Experienced finance executive Sung Lee joins the board.

3. Dec 17

   Conference participation

   24h Move

   -2.0%

   Corporate presentation at J.P. Morgan Healthcare Conference announced.

4. Nov 26

   Conference participation

   24h Move

   +1.8%

   Piper Sandler healthcare conference fireside chat participation disclosed.

5. Nov 12

   Conference participation

   24h Move

   -8.5%

   Jefferies Global Healthcare Conference fireside chat participation announced.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026 at 2:00 PM EST.

The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.

Investors and Media:

Elizabeth Hickin
IR@tangotx.com
media@tangotx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Tango Therapeutics (TNGX) present at the Guggenheim Emerging Outlook: Biotech Summit 2026?

Tango Therapeutics will present on Thursday, February 12, 2026 at 2:00 PM EST. According to Tango Therapeutics, Malte Peters, M.D., President and CEO, is scheduled for a fireside chat at that time.

How can investors watch the Tango Therapeutics (TNGX) fireside chat on February 12, 2026?

Investors can watch via a live webcast available on the company’s investor site under Events & Presentations. According to Tango Therapeutics, the webcast will be accessible on the Investors page the day of the event.

Will a replay of the Tango Therapeutics (TNGX) Guggenheim presentation be available after the event?

Yes, a replay will be archived for 90 days on the company website. According to Tango Therapeutics, the replay will be posted after the presentation and remain available for three months.

Who from Tango Therapeutics (TNGX) will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026?

Malte Peters, M.D., President and Chief Executive Officer, will participate in a fireside chat. According to Tango Therapeutics, he is scheduled to speak on February 12, 2026 at 2:00 PM EST.